Hydrogels derived from demineralized and decellularized bone extracellular matrix

Acta Biomaterialia

Volumn 9, Issue 8, 2013, Pages 7865-7873

  Sawkins, M J ^a   Bowen, W ^a   Dhadda, P ^a   Markides, H ^a   Sidney, L E ^a   Taylor, A J ^a   Rose, F R A J ^a   Badylak, S F ^b   Shakesheff, K M ^a   White, L J ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Bone graft; Decellularization; Demineralized bone matrix; Extracellular matrix; Hydrogel

Indexed keywords

BONE; GELATION; GROWTH KINETICS; HISTOLOGY; LIQUIDS; MAMMALS; SCAFFOLDS (BIOLOGY);

BONE GRAFT; CARRIER LIQUID; COMPLEX TISSUES; DECELLULARIZATION; DECELLULARIZED; DEMINERALIZED BONE MATRIX; EXTRACELLULAR MATRICES; MAMMALIAN TISSUES; SITE-SPECIFIC; TISSUE FORMATION;

HYDROGELS;

COLLAGEN TYPE 1; MINERAL; BONE PROSTHESIS; HYDROGEL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE DEMINERALIZATION; BONE DEVELOPMENT; BONE MATRIX; CALVARIA; CATTLE; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CHEMICAL COMPOSITION; CHEMICAL STRUCTURE; CONTROLLED STUDY; DECELLULARIZATION; DEMINERALIZED BONE MATRIX; EXTRACELLULAR MATRIX; FLOW KINETICS; GELATION; HYDROGEL; IN VITRO STUDY; INFLAMMATION; KINETICS; LIQUID; MORPHOLOGY; MOUSE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; TIBIA; TURBIDIMETRY; ANIMAL; BONE PROSTHESIS; CELL FREE SYSTEM; CHEMISTRY; CYTOLOGY; ISOLATION AND PURIFICATION; MATERIALS TESTING; SYNTHESIS; BOVINAE;

BOVINAE; MAMMALIA;

ANIMALS; BONE SUBSTITUTES; CATTLE; CELL-FREE SYSTEM; CELLS, CULTURED; EXTRACELLULAR MATRIX; HYDROGELS; MATERIALS TESTING; MINERALS; TIBIA;

EID: 84891703291     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2013.04.029     Document Type: Article

References (55)

1. Badylak SF. The extracellular matrix as a biologic scaffold material. Biomaterials 2007;28:3587-93.
2. Badylak SF, Kochupura PV, Cohen IS, Doronin SV, Saltman AE, Gilbert TW, et al. The use of extracellular matrix as an inductive scaffold for the partial replacement of functional myocardium. Cell Transplant 2006;15:S29-40.
3. Quarti A, Nardone S, Colaneri M, Santoro G, Pozzi M. Preliminary experience in the use of an extracellular matrix to repair congenital heart diseases. Interact Cardiovasc Thorac Surg 2011;13:569-72.
4. Badylak SF, Vorp DA, Spievack AR, Simmons-Byrd A, Hanke J, Freytes DO, et al. Esophageal reconstruction with ECM and muscle tissue in a dog model. J Surg Res 2005;128:87-97.
5. Turner NJ, Yates AJ, Weber DJ, Qureshi IR, Stolz DB, Gilbert TW, et al. Xenogeneic extracellular matrix as an inductive scaffold for regeneration of a functioning musculotendinous junction. Tissue Eng Part A 2010; 16:3309-17.
6. Valentin JE, Turner NJ, Gilbert TW, Badylak SF. Functional skeletal muscle formation with a biologic scaffold. Biomaterials 2010;31:7475-84.
7. Badylak SF. The extracellular matrix as a scaffold for tissue reconstruction. Semin Cell Dev Biol 2002;13:377-83.
8. Wolf MT, Daly KA, Reing JE, Badylak SF. Biologic scaffold composed of skeletal muscle extracellular matrix. Biomaterials 2012;33:2916-25.
9. Beattie AJ, Gilbert TW, Guyot JP, Yates AJ, Badylak SF. Chemoattraction of progenitor cells by remodeling extracellular matrix scaffolds. Tissue Eng Part A 2009;15:1119-25.
10. Reing JE, Zhang L, Myers-Irvin J, Cordero KE, Freytes DO, Heber-Katz E, et al. Degradation products of extracellular matrix affect cell migration and proliferation. Tissue Eng Part A 2009;15:605-14.
11. Vorotnikova E, McIntosh D, Dewilde A, Zhang J, Reing JE, Zhang L, et al. Extracellular matrix-derived products modulate endothelial and progenitor cell migration and proliferation in vitro and stimulate regenerative healing in vivo. Matrix Biol. 2010;29:690-700.
12. Valentin JE, Badylak JS, McCabe GP, Badylak SF. Extracellular matrix bioscaffolds for orthopaedic applications. A comparative histologic study. J Bone Joint Surg Am 2006;88:2673-86.
13. Brown BN, Valentin JE, Stewart-Akers AM, McCabe GP, Badylak SF. Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component. Biomaterials 2009;30: 1482-91.
14. Sellaro TL, Ranade A, Faulk DM, McCabe GP, Dorko K, Badylak SF, et al. Maintenance of human hepatocyte function in vitro by liver-derived extracellular matrix gels. Tissue Eng Part A 2010;16:1075-82.
15. Cortiella J, Niles J, Cantu A, Brettler A, Pham A, Vargas G, et al. Influence of acellular natural lung matrix on murine embryonic stem cell differentiation and tissue formation. Tissue Eng Part A 2010;16:2565-80.
16. Petersen TH, Calle EA, Zhao L, Lee EJ, Gui L, Raredon MB, et al. Tissueengineered lungs for in vivo implantation. Science 2010;329:538-41.
17. Uygun BE, Soto-Gutierrez A, Yagi H, Izamis M-L, Guzzardi MA, Shulman C, et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med 2010;16:814-20.
18. Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ 2003;81:646-56.
19. Jahangir AA, Nunley RM, Mehta S, Sharan AD. Bone-graft substitutes in orthopaedic surgery. AAOS 2008;2:1.
20. Evaluation criteria for musculoskeletal and craniofacial tissue engineering constructs: a conference report. Tissue Eng Part A 2008;14:2089-2104.
21. Dinopoulos H, Dimitriou R, Giannoudis PV. Bone graft substitutes: what are the options? The Surgeon 2012;10:230-9.
22. Guldberg RE. Spatiotemporal delivery strategies for promoting musculoskeletal tissue regeneration. J Bone Miner Res 2009;24:1507-11.
23. Greenwald AS, Boden SD, Goldberg VM, Khan Y, Laurencin CT, Rosier RN. Bonegraft substitutes: facts, fictions, and applications. J Bone Joint Surg 2001;83: S98-S103.
24. Peterson B, Whang PG, Iglesias R, Wang JC, Lieberman JR. Osteoinductivity of commercially available demineralized bone matrix preparations in a spine fusion model. J Bone Joint Surg 2004;86:2243-50.
25. Wang JC, Alanay A, Mark D, Kanim LE, Campbell PA, Dawson EG, et al. A comparison of commercially available demineralized bone matrix for spinal fusion. Eur Spine J 2007;16:1233-40.
26. De Long WG, Einhorn TA, Koval K, McKee M, Smith W, Sanders R, et al. Bone grafts and bone graft substitutes in orthopaedic trauma surgery: a critical analysis. J Bone Joint Surg 2007;89:649-58.
27. Gruskin E, Doll BA, Futrell FW, Schmitz JP, Hollinger JO. Demineralized bone matrix in bone repair: history and use. Adv Drug Deliv Rev 2012;64: 1063-77.
28. Bostrom MP, Yang X, Kennan M, Sandhu H, Dicarlo E, Lane JM. An unexpected outcome during testing of commercially available demineralized bone graft materials: how safe are the nonallograft components? Spine (Phila Pa 1976) 2001;26:1425-8.
29. Acarturk TO, Hollinger JO. Commercially available demineralized bone matrix compositions to regenerate calvarial critical-sized bone defects. Plast Reconstr Surg 2006;118:862-73.
30. Markel DC, Guthrie ST, Wu B, Song Z, Wooley PH. Characterization of the inflammatory response to four commercial bone graft substitutes using a murine biocompatibility model. J Inflamm Res 2012;5:13-8.
31. Yazdi M, Bernick S, Paule WJ, Nimni ME. Postmortem degradation of demineralized bone matrix osteoinductive potential. Effect of time and storage temperature. Clin Orthop Relat Res 1991;262:281-5.
32. Lomas RJ, Gillan HL, Matthews JB, Ingham E, Kearney JN. An evaluation of the capacity of differently prepared demineralised bone matrices (DBM) and toxic residuals of ethylene oxide (EtOx) to provoke an inflammatory response in vitro. Biomaterials 2001;22:913-21.
33. Pietrzak WS, Ali SN, Chitturi D, Jacob M, Woodell-May JE. BMP depletion occurs during prolonged acid demineralization of bone: characterization and implications for graft preparation. Cell Tissue Bank 2011;12:81-8.
34. Schenke-Layland K, Vasilevski O, Opitz F, König K, Riemann I, Halbhuber KJ, et al. Impact of decellularization of xenogeneic tissue on extracellular matrix integrity for tissue engineering of heart valves. J Struct Biol 2003;143:201-8.
35. Hong Y, Huber A, Takanari K, Amoroso NJ, Hashizume R, Badylak SF, et al. Mechanical properties and in vivo behavior of a biodegradable synthetic polymer microfiber - extracellular matrix hydrogel biohybrid scaffold. Biomaterials 2011;32:3387-94.
36. Gilbert TW, Freund JM, Badylak SF. Quantification of DNA in biologic scaffold materials. J Surg Res 2009;152:135-9.
37. Keane TJ, Londono R, Turner NJ, Badylak SF. Consequences of ineffective decellularization of biologic scaffolds on the host response. Biomaterials 2012;33:1771-81.
38. Woessner JF. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 1961;93:440-7.
39. Freytes DO, Martin J, Velankar SS, Lee AS, Badylak SF. Preparation and rheological characterization of a gel form of the porcine urinary bladder matrix. Biomaterials 2008;29:1630-7.
40. Wolf MT, Daly KA, Brennan-Pierce EP, Johnson SA, Carruthers CA, D'Amore A, et al. A hydrogel derived from decellularized dermal extracellular matrix. Biomaterials 2012;33:7028-38.
41. Reing JE, Brown BN, Daly KA, Freund JM, Gilbert TW, Hsiong SX, et al. The effects of processing methods upon mechanical and biologic properties of porcine dermal extracellular matrix scaffolds. Biomaterials 2010;31:8626-33.
42. Crapo PM, Gilbert TW, Badylak SF. An overview of tissue and whole organ decellularization processes. Biomaterials 2011;32:3233-43.
43. Wood GC. The formation of fibrils from collagen solutions. 2. A mechanism of collagen-fibril formation. Biochem J 1960;75:598-605.
44. Wood GC, Keech MK. The formation of fibrils from collagen solutions. 1. The effect of experimental conditions: kinetic and electron-microscope studies. Biochem J 1960;75:588-98.
45. Brightman AO, Rajwa BP, Sturgis JE, McCallister ME, Robinson JP, Voytik-Harbin SL. Time-lapse confocal reflection microscopy of collagen fibrillogenesis and extracellular matrix assembly in vitro. Biopolymers 2000; 54:222-34.
46. Y.-l. Yang, Kaufman LJ. Rheology and confocal reflectance microscopy as probes of mechanical properties and structure during collagen and collagen/ hyaluronan self-assembly. Biophys J 2009;96:1566-85.
47. Stuart K, Panitch A. Influence of chondroitin sulfate on collagen gel structure and mechanical properties at physiologically relevant levels. Biopolymers 2008;89:841-51.
48. Yang M, Chen CZ, Wang XN, Zhu YB, Gu YJ. Favorable effects of the detergent and enzyme extraction method for preparing decellularized bovine pericardium scaffold for tissue engineered heart valves. J Biomed Mater Res B Appl Biomater 2009;91:354-61.
49. DeQuach JA, Lin JE, Cam C, Hu D, Salvatore MA, Sheikh F, et al. Injectable skeletal muscle matrix hydrogel promotes neovascularization and muscle cell infiltration in a hindlimb ischemia model. Eur Cell Mater 2012;23:400-12.
50. Badylak SF, Gilbert TW. Immune response to biologic scaffold materials. Semin Immunol 2008;20:109-16.
51. Galili U. The [alpha]-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy. Immunol Cell Biol 2005; 83:674-86.
52. Raeder RH, Badylak SF, Sheehan C, Kallakury B, Metzger DW. Natural antigalactose a1,3 galactose antibodies delay, but do not prevent the acceptance of extracellular matrix xenografts. Transpl Immunol 2002;10:15-24.
53. Daly KA, Stewart-Akers AM, Hara H, Ezzelarab M, Long C, Cordero K, et al. Effect of the aGal epitope on the response to small intestinal submucosa extracellular matrix in a nonhuman primate model. Tissue Eng Part A 2009;15: 3877-88.
54. Yoshida R, Vavken P, Murray MM. Decellularization of bovine anterior cruciate ligament tissues minimizes immunogenic reactions to alpha-gal epitopes by human peripheral blood mononuclear cells. Knee 2012;19:672-5.
55. Hadjipanayi E, Mudera V, Brown RA. Close dependence of fibroblast proliferation on collagen scaffold matrix stiffness. J Tissue Eng Regen Med 2009;3:77-84.